Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Lidocaine; Prilocaine Patent Expiration

Lidocaine; Prilocaine is used for managing pain and discomfort during periodontal scaling and root planning procedures. It was first introduced by Teva Branded Pharmaceutical Products R And D Inc in its drug Emla on Dec 30, 1992. Another drug containing Lidocaine; Prilocaine is Oraqix. 11 different companies have introduced drugs containing Lidocaine; Prilocaine.


Lidocaine; Prilocaine Patents

Given below is the list of patents protecting Lidocaine; Prilocaine, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Oraqix US6031007 Pharmaceutical composition with anaesthetic effect Apr 01, 2017

(Expired)

 Dentsply Pharm



Lidocaine; Prilocaine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lidocaine; Prilocaine Generic API Manufacturers

Several generic applications have been filed for Lidocaine; Prilocaine. The first generic version for Lidocaine; Prilocaine was by Fougera Pharmaceuticals Inc and was approved on Aug 18, 2003. And the latest generic version is by Zydus Lifesciences Ltd and was approved on Dec 17, 2024.

Given below is the list of companies who have filed for Lidocaine; Prilocaine generic, along with the locations of their manufacturing plants worldwide.